LANCET ONCOL 润色咨询

LANCET ONCOLOGY

出版年份:2000 年文章数:1511 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:1.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=6f9e6606, cover=https://img.medsci.cn/images/journal/cover/2021/TzW_202109271315563170.jpg, fullname=LANCET ONCOLOGY, abbr=LANCET ONCOL, pyear=2000, frequence=Monthly, articleNumbers=1511, citedSelf2015=1.7, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均1.4月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1470-2045, greenSci=https://www.greensci.net/search?kw=1470-2045, scijournal=https://www.scijournal.org/impact-factor-of-LANCET-ONCOL.shtml, medsciHotlightString=null, medsciHotlightRealtime=12.381, medsciHotlight=7.882, medsciHotlight5year=8.98168, citescore=0.0, hIndex=324, impactFactor=51.1, orgnization=Lancet Publishing Group, orgnizationUrl=http://www.elsevier.com, country=United Kingdom, countryCn=英国, isOa=0, isOaString=否, sciScie=Science Citation Index Expanded|Current Contents - Clinical Medicine, bigclassCas=医学 1区[Top], smallclassCas=医学 1 区, website=http://www.thelancet.com/journals/lanonc/issue/current, websiteHits=20259, guideForAuthor=http://www.thelancet.com/lanonc/information-for-authors, guideForAuthorHits=5541, submitWebsite=https://ees.elsevier.com/thelancetoncology/, submitWebsiteHits=8154, content=<p>PUBLISHED BY THE LANCET. ISSN: 1470-2045.<br /><br />THE LANCET ONCOLOGY IS A MONTHLY, REVIEW JOURNAL, WITH ARTICLES, VIEWPOINTS, NEWS AND REVIEWS IN ONCOLOGY.</p> <div> </div> <div> <h2 style="margin: 0px; text-rendering: optimizeLegibility;">HISTORY</h2> <p style="margin: 0px 0px 1.2em;"><span class="jrnl-name">THE LANCET ONCOLOGY</span> WAS LAUNCHED IN SEPTEMBER, 2000, AS A LIVELY AND INFORMATIVE MONTHLY JOURNAL COVERING INTERNATIONAL ISSUES RELEVANT TO CLINICAL CANCER SPECIALISTS WORLDWIDE. IN MAY, 2005, THE JOURNAL EXPANDED TO INCLUDE ORIGINAL RESEARCH AND BEGAN PUBLISHING ARTICLES ONLINE FIRST PRIOR TO PRINT PUBLICATION. THE JOURNAL QUICKLY ESTABLISHED ITSELF AS ONE OF THE PREMIER PUBLICATIONS WORLDWIDE FOR ORIGINAL RESEARCH, ESPECIALLY REPORTS FROM CLINICAL TRIALS, AND IN THE AREAS OF ADVOCACY AND GLOBAL HEALTH. UNIQUELY, ALL ORIGINAL RESEARCH IS PEER-REVIEWED VIA A FAST-TRACK SERVICE, AND SUCCESSFUL PAPERS ARE PUBLISHED WITHIN 8 WEEKS OF SUBMISSION. IN 2008, THE JOURNAL EXPANDED ITS ONLINE PRESENCE TO INCLUDE REGULAR PODCASTS.</p> <p style="margin: 0px 0px 1.2em;"><span class="jrnl-name">THE LANCET ONCOLOGY</span> HAS ALSO DEVELOPED A REPUTATION FOR HOSTING EVENTS FOR ONCOLOGISTS, CANCER RESEARCHERS, AND POLICYMAKERS. IN 2007, <span class="jrnl-name">THE LANCET ONCOLOGY</span> CONVENED ITS FIRST CONFERENCE IN SINGAPORE ENTITLED <span class="jrnl-name">ASIA AND CANCER MANAGEMENT</span>IN THE 21ST CENTURY. ADDITIONALLY IN 2007, THE JOURNAL HOSTED A PLENARY LECTURE AT THE <span class="jrnl-name">ONCOLOGY CONGRESS</span> IN SAN FRANCISCO, CA, USA, ON THE TOPIC OF DEVELOPMENTAL BIOLOGY, SELF RENEWAL, AND CANCER. IN SUBSEQUENT YEARS, THE JOURNAL HOSTED A SECOND PLENARY LECTURE AT THE 2008 <span class="jrnl-name">ONCOLOGY CONGRESS</span>, AND THE INAUGURAL <span class="jrnl-name">ASIAN ONCOLOGY SUMMIT</span> IN 2009. IN 2010, <span class="jrnl-name">THE LANCET ONCOLOGY</span>''''''''S INVOLVEMENT IN CONFERENCES EXPANDED WITH FURTHER EVENTS, INCLUDING A SECOND <span class="jrnl-name">ASIAN ONCOLOGY SUMMIT</span> IN BALI, INDONESIA, AND A CONFERENCE ON <span class="jrnl-name">HPV AND CANCER</span> IN AMSTERDAM, THE NETHERLANDS. SINCE 2011, THE JOURNAL HAS CONTINUED TO HOST THE SUCCESSFUL <span class="jrnl-name">ASIAN ONCOLOGY SUMMITS</span> AND IN 2015, <span class="jrnl-name">THE LANCET ONCOLOGY</span> WILL HOST THE 7TH <span class="jrnl-name">ASIAN ONCOLOGY SUMMIT</span> TO TAKE PLACE APRIL 10-12, 2015 IN SHANGHAI, CHINA. FURTHER EVENTS ARE PLANNED FOR 2016 AND BEYOND. THE JOURNAL IS ALSO INVOLVED IN CANCER HEALTH-CARE ADVOCACY BY PARTNERING WITH SPECIFIC ORGANISATIONS AND SOCIETIES.</p> <h2 style="margin: 0px; text-rendering: optimizeLegibility;">REPUTATION AND IMPACT</h2> <p style="margin: 0px 0px 1.2em;"><span class="jrnl-name">THE LANCET ONCOLOGY</span> HAS AN IMPACT FACTOR OF 24·725. THE JOURNAL RANKS THIRD OUT OF 202 ONCOLOGY JOURNALS WORLDWIDE, IS THE LEADING CLINICAL ONCOLOGY RESEARCH JOURNAL, AND IS IN THE TOP 0·5% OF ALL SCIENTIFIC JOURNALS, OF ANY DISCIPLINE, GLOBALLY (2013 JOURNAL CITATION REPORTS®, THOMSON REUTERS 2014). ARTICLES PUBLISHED IN <span class="jrnl-name">THE LANCET ONCOLOGY</span> REGULARLY RECEIVE COVERAGE IN THE MAINSTREAM PRINT, ONLINE, AND BROADCAST MEDIA.</p> <h2 style="margin: 0px; text-rendering: optimizeLegibility;">COVERAGE</h2> <p style="margin: 0px 0px 1.2em;">THE AIM OF <span class="jrnl-name">THE LANCET ONCOLOGY</span> IS TO PUBLISH INTERESTING, INFORMATIVE, AND PRACTICE-CHANGING ARTICLES ON ANY TOPIC CONNECTED WITH CLINICAL ONCOLOGY. TOPICS INCLUDE, BUT ARE NOT LIMITED TO:</p> <ul style="margin: 0px 0px 0px 20px; padding: 0px;"> <li>BREAST CANCER</li> <li>ENDOCRINE SYSTEM CANCER</li> <li>GASTROINTESTINAL CANCER</li> <li>GENITOURINARY CANCER</li> <li>GYNAECOLOGICAL CANCER</li> <li>HAEMATOLOGICAL CANCER</li> <li>HEAD AND NECK CANCER</li> <li>NEUROONCOLOGY</li> <li>PAEDIATRIC ONCOLOGY</li> <li>THORACIC ONCOLOGY</li> <li>SARCOMA</li> <li>SKIN CANCER</li> <li>EPIDEMIOLOGY, CANCER PREVENTION, AND CANCER CONTROL</li> <li>SUPPORTIVE CARE</li> <li>IMAGING</li> <li>HEALTH-CARE SYSTEMS</li> </ul> </div>, totalCites=77245, brief=LANCET ONCOL杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=肿瘤学" >肿瘤学</a></strong>”子行业的顶级杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=LANCET ONCOL 在该细分领域可能是国际一流杂志,但是国内关注少,可能与很难投中有关吧,可以试试,但不要报过高中的期望哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=6f9e6606'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=10), ImpactFactorTagDto(id=516, tagName=癌症, createdHits=6), ImpactFactorTagDto(id=277, tagName=NSCLC, createdHits=2), ImpactFactorTagDto(id=10749, tagName=创新药物, createdHits=1), ImpactFactorTagDto(id=285, tagName=乳腺癌, createdHits=1), ImpactFactorTagDto(id=56699, tagName=微创介入, createdHits=1), ImpactFactorTagDto(id=669, tagName=实体瘤, createdHits=1), ImpactFactorTagDto(id=428, tagName=肺癌, createdHits=1), ImpactFactorTagDto(id=1518, tagName=随机对照试验, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=10.24), GetImpactFactorCiteScoreListResponse(year=2017, citescore=10.35), GetImpactFactorCiteScoreListResponse(year=2018, citescore=10.07), GetImpactFactorCiteScoreListResponse(year=2019, citescore=49.4), GetImpactFactorCiteScoreListResponse(year=2020, citescore=0.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=9.692), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=10.232), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=11.661), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=16.739), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=12.381)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=6/321)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1470-2045[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=LANCET ONCOLOGY[ta], article_number=505, article_number_cn=25, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
LANCET ONCOL/LANCET ONCOLOGY
ISSN
1470-2045
影响指数话题
预警等级
MedSci期刊指数
12.381 (MedSci实时期刊指数) | 8.98168 (5年期刊指数)
CiteScore值
0.0
h-index
324
h5-median
暂无数据
出版社/管理机构
杂志由 Lancet Publishing Group 出版或管理
出版国家/地区
United Kingdom 英国
出版周期
Monthly
出版年份
2000
是否OA
被收录情况
Science Citation Index Expanded|Current Contents - Clinical Medicine
JCR分区
暂无数据
中科院分区
大类:医学 1区[Top]
小类:医学 1 区